ClinVar Miner

Submissions for variant NM_006261.5(PROP1):c.386_387dup (p.Ser130fs)

dbSNP: rs1554182405
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000673350 SCV000798540 likely pathogenic Pituitary hormone deficiency, combined, 2 2018-03-14 criteria provided, single submitter clinical testing
Invitae RCV001388459 SCV001589458 pathogenic not provided 2021-06-24 criteria provided, single submitter clinical testing This variant has not been reported in the literature in individuals with PROP1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the PROP1 gene (p.Ser130Alafs*36). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 97 amino acids of the PROP1 protein. This variant disrupts the C-terminus of the PROP1 protein. Other variant(s) that disrupt this region (p.Trp194*) have been determined to be pathogenic (PMID: 15941866, 20381582, Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV000673350 SCV004206533 likely pathogenic Pituitary hormone deficiency, combined, 2 2023-08-19 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.